...
首页> 外文期刊>Nutrition Journal >A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union
【24h】

A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union

机译:系统审查过程及其用于评估欧盟益生菌食品的健康索赔证据的适用性

获取原文

摘要

This paper addresses the use of systematic review and meta-analysis to evaluate the strength of evidence for health benefits of probiotic foods, especially relating to health claim substantiation in the European Union. A systematic review is a protocol-driven, transparent and replicable approach, widely accepted in a number of scientific fields, and used by many policy-setting organizations to evaluate the strength of evidence to answer a focused research question. Many systematic reviews have been published on the broad category of probiotics for many different outcomes. Some of these reviews have been criticized for including poor quality studies, pooling heterogeneous study results, and not considering publication bias. Well-designed and -conducted systematic reviews should address such issues. Systematic reviews of probiotics have an additional challenge – rarely addressed in published reviews - in that there must be a scientifically sound basis for combining evidence on different strains, species or genera. The European Food Safety Authority (EFSA) is increasingly adopting the systematic review methodology. It remains to be seen how health claims supported by systematic reviews are evaluated within the EFSA approval process. The EFSA Panel on Dietetic Products, Nutrition and Allergies deems randomized trials to be the best approach to generating evidence about the effects of foods on health outcomes. They also acknowledge that systematic reviews (with or without meta-analyses) are the best approach to assess the totality of the evidence. It is reasonable to use these well-established methods to assess objectively the strength of evidence for a probiotic health claim. Use of the methods to combine results on more than a single strain or defined blend of strains will require a rationale that the different probiotics are substantively similar, either in identity or in their mode of action.
机译:本文涉及系统审查和荟萃分析,以评估益生菌食品健康益处的证据,特别是与欧洲联盟的健康索赔实证有关。系统审查是一种协议驱动,透明和可复制的方法,在许多科学领域中广泛接受,并由许多政策制定组织使用,以评估证据的实力来回答重点的研究问题。许多系统评论已发表于许多不同结果的广泛类别的益生菌上。其中一些评论被批评,包括差的质量研究,汇集异质研究结果,而不是考虑出版物偏见。精心设计和 - 导信系统的审查应解决此类问题。对益生菌的系统审查有额外的挑战 - 很少在发布的评论中解决 - 因为必须有一种科学的基础,可以组合在不同菌株,物种或属的证据。欧洲食品安全管理局(EFSA)越来越多地采用系统审查方法。它仍然可以看出如何在EFSA批准过程中评估系统评论的健康声称如何。 EFSA营养产品,营养和过敏课程认为随机试验是为食品对健康结果产生影响的最佳方法。他们还承认,系统评价(有或没有Meta-Analyzes)是评估证据整体的最佳方法。使用这些良好的方法是合理的,以客观地评估益生菌健康索赔的证据强度。使用方法将结果与菌株的多个菌株或定义的混合物相结合将需要一个理由,即不同的益生菌在身份或其作用模式中具有基本类似的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号